The 20 Best Eccrine Porocarcinoma Doctors Near Me in Maryland, US

Dr. William H. Sharfman is an associate professor of oncology and dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous oncology, dermatology and immunotherapy. He helped create the well-established Melanoma Program at the Johns Hopkins Kimmel Cancer Center in 1994. Dr. Sharfman serves as the director of cutaneous oncology and clinical co-director for oncology at the Johns Hopkins Melanoma Program. He earned his M.D. from the University of Toledo College of Medicine. He completed his residency at Cleveland Clinic and performed a fellowship in hematology and oncology at Cleveland Clinic. Dr. Sharfman's research interests include novel therapies for high risk and advanced melanoma patients. Dr. Sharfman is rated as a Distinguished provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Eccrine Porocarcinoma, and Familial Pancreatic Cancer. Dr. Sharfman is board certified in American Board Of Internal Medicine.

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as an Advanced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, Melanoma of the Eye, and Pancreaticoduodenectomy. Dr. Lipson is board certified in American Board Of Internal Medicine.

Dr. Julie Lange is an assistant professor of surgery, dermatology and oncology at the Johns Hopkins University School of Medicine. Dr. Lange was one of the original members of the Johns Hopkins melanoma group when it was first formed in 1995 and now serves as a clinical co-director of the Melanoma Program. Dr. Lange introduced the sentinel node technique to Johns Hopkins for both melanoma and breast cancer in the 1990s and has extensive experience with this technique. Dr. Lange is a graduate of the Vanderbilt University School of Medicine and completed her general surgery training at Yale-New Haven Hospital. She completed a fellowship in surgical oncology and immunotherapy at the Surgery Branch of the National Cancer Institute as well. Dr. Lange joined the faculty of the Department of Surgery at Johns Hopkins in 1994 and subsequently earned a Sc.M. in clinical investigation at the Johns Hopkins Bloomberg School of Public Health. She has particular interest in melanoma at extremes of age, and in the factors associated with variance in melanoma care. Dr. Lange has published the largest study of melanoma in children, adolescents and young adults. She recognizes that melanoma in the older patient is a growing epidemic and has investigated the socioeconomic, demographic and healthcare factors that influence the treatment of melanoma in older persons. Dr. Lange is a member of the melanoma panel of the National Comprehensive Cancer Network, a group that annually evaluates and revises national treatment guidelines for melanoma. In 2015, she was inducted for her work into the Miller-Coulson Academy of Clinical Excellence, which recognizes outstanding clinicians at Johns Hopkins based on a number of factors, including communication and interpersonal skills, professionalism and humanism, a scholarly approach to clinical practice, and a passion for patient care. Dr. Lange is rated as an Advanced provider by MediFind in the treatment of Eccrine Porocarcinoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Lymphadenectomy. Dr. Lange is board certified in American Board Of Surgery.

Teresa Diaz is an Obstetrics and Gynecologist practicing medicine in Baltimore, Maryland. Dr. Diaz is rated as a Distinguished provider by MediFind in the treatment of Eccrine Porocarcinoma. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Endometrial Stromal Sarcoma, Vulvar Cancer, Ureteroscopy, and Hysterectomy.

Flavio Kruter is an Oncologist practicing medicine in Westminster, Maryland. Dr. Kruter is rated as a Distinguished provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 88 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Hemangioma Thrombocytopenia Syndrome, Essential Thrombocythemia, and Bone Marrow Aspiration.

Dr. John Migaly is a distinguished colorectal surgeon and Chief of the Division of Colorectal Surgery/Ravitch Division at Johns Hopkins Medicine. He specializes in the treatment of colorectal cancer, inflammatory bowel disease, and other benign and complex colorectal conditions. Dr. Migaly is committed to providing advanced, patient-centered care, often using minimally invasive techniques including laparoscopic and robotic surgery, to help reduce recovery time and improve outcomes. Dr. Migaly comes to Johns Hopkins Medicine from the Duke University School of Medicine, serving from 2008-2024 on the surgery faculty treating patients primarily through the Duke Cancer Institute. He was elevated to Program Director of the General Surgery Residency in 2012, and subsequently served as Vice Chair of Education until 2024. His work was critical to the success of the undergraduate, graduate, and continuing medical education missions at Duke Surgery. Dr. Migaly earned his B.A. in Biochemistry from New York University and his medical degree from the New York University School of Medicine. He completed surgical residency and a research fellowship at Temple University Health Sciences Center, and colorectal surgery fellowship at Cleveland Clinic Florida. Dr. Migaly’s career has been marked not only by a complex and high-volume clinical colon and rectal surgery practice, but also a commitment to research and education, supported by greater than 200 publications, book chapters, and presentations. His research is centered around improving practice patterns and outcomes in colorectal cancer care and recovery. His leadership and dedication to advancing the field of colorectal surgery is evident through his service on committees that shape how colorectal care is delivered nationally, via his past and present service on the Program Committee, the Clinical Practice Guidelines Committee and the Diversity and Inclusion Committee of the American Society of Colon and Rectal Surgeons. Videos John Migaly, M.D.Chief of Colorectal Surgery"". Dr. Migaly is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Anal Cancer, Gastrointestinal Fistula, Colostomy, and Ileostomy. Dr. Migaly is board certified in American Board Of Colon And Rectal Surgery and American Board Of Surgery.

Dr. Meyer will serve as the lead medical oncologist for adult sarcoma patients, and will focus on building the Adult Sarcoma and Connective Tissue Oncology Program. In collaboration with pediatric oncologist David Loeb, M.D., Ph.D., and orthopaedic surgeon Kristy Weber, M.D., Meyer will bring novel therapies to the clinic for sarcoma patients. Meyer received his bachelors and masters degrees in cell and molecular biology from Stanford University. From there, he joined the Medical Scientist Training Program at Baylor College of Medicine and earned his medical degree followed by a doctorate in immunology. Meyer completed his residency at the University of Maryland and served as chief resident in medicine from 2004-2005. Afterward, he joined our fellowship program in medical oncology and has been working in the laboratory of Jonathan Powell, M.D., Ph.D., on projects relating to the characterization of molecular regulatory pathways involved in T-cell activation and energy. As a third-year fellow, Meyer served as the chief fellow for our Training Programs in Hematology and Medical Oncology and he received a Young Investigator Award from the American Society of Clinical Oncology in 2010. Dr. Meyer is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Ganglioneuroblastoma, and Bone Tumor. Dr. Meyer is board certified in American Board Of Internal Medicine.

Fong W. Liu, M.D., M.P.H., is an assistant professor at the Johns Hopkins University School of Medicine. Her clinical expertise includes gynecologic oncology and general gynecology and obstetrics. Dr. Liu earned her Doctor of Medicine degree from the University of Alabama. She completed her residency in obstetrics and gynecology at Beth Israel Deaconess Medical Center in Boston, Massachusetts. Dr. Liu then went on to complete her fellowship in gynecologic oncology at the University of California, Irvine. Prior to joining Johns Hopkins, Dr. Liu served as an instructor in the department of obstetrics and gynecology at Beth Israel Deaconess Medical Center. Dr. Liu is also a gynecologic oncologist at the Sandra and Malcolm Berman Cancer Institute at GBMC. Dr. Liu is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Endometrial Cancer, Oophorectomy, and Hernia Surgery. Dr. Liu is board certified in American Board Of Obstetrics And Gynecology.

Dr. Harry Quon is an associate professor of radiation oncology and molecular radiation sciences at the Johns Hopkins University School of Medicine. He also holds appointments in oncology and in otolaryngology - head and neck surgery. His area of clinical expertise is radiation treatment for head and neck cancers. He serves as the co-director of the Johns Hopkins Head and Neck Cancer Multidisciplinary Clinic. Dr. Quon received his M.D. from the University of Toronto Institute of Medical Science. He completed his residency at the Princess Margaret Hospital in Ontario and performed a fellowship in radiation oncology at the Princess Margaret Hospital and the Beth Israel Medical Center. Make A Gift. Dr. Quon is rated as an Advanced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Dry Mouth, Gastrostomy, and Prostatectomy. Dr. Quon is board certified in American Board Of Radiology.

Oanh Lauring is a Dermatologist practicing medicine in Middle River, Maryland. Dr. Lauring is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. She is also highly rated in 80 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Warts, Intertrigo, and Rosacea.

Min Deng is a Dermatologist practicing medicine in Chevy Chase, Maryland. Dr. Deng is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Acne, and Bowen's Disease.

Naeem Newman is a General Surgeon practicing medicine in Annapolis, Maryland. Dr. Newman is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Familial Pancreatic Cancer, Hernia Surgery, and Hepatectomy.

Jeffrey Wolf is a General Surgeon practicing medicine in Baltimore, Maryland. Dr. Wolf is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Acinic Cell Carcinoma of Salivary Glands, Thyroidectomy, and Gastrostomy.

Joseph Bennett is a Surgical Oncologist practicing medicine in Baltimore, Maryland. Dr. Bennett is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 63 other conditions, according to our data. His clinical expertise encompasses Pancreatic Adenoma, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

Glen Gibson is a General Surgeon practicing medicine in Annapolis, Maryland. Dr. Gibson is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Melanoma, Familial Colorectal Cancer, Hernia Surgery, and Hepatectomy.

Sylwester Dziuba is a Radiation Oncologist practicing medicine in Baltimore, Maryland. Dr. Dziuba is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Lung Cancer, and Pleuropulmonary Blastoma.

Maral Skelsey is a Dermatologist practicing medicine in Chevy Chase, Maryland. Dr. Skelsey is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. She is also highly rated in 79 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Melanoma, Warts, and Seborrheic Keratosis. Dr. Skelsey is board certified in American Board Of Dermatology.

Daniel Kelley is a General Surgeon practicing medicine in Salisbury, Maryland. Dr. Kelley is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Hearing Loss, Infant Hearing Loss, Empyema, and Sinusitis.

Rodney Taylor is a General Surgeon practicing medicine in Baltimore, Maryland. Dr. Taylor is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Olfactory Neuroblastoma, Sinus Cancer, Teratocarcinosarcoma, Laryngectomy, and Tissue Biopsy.

Abhishek Kalla is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Kalla is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Pancreatic Cancer, Familial Pancreatic Cancer, and Familial Prostate Cancer.